SEC 13F Intelligence

Royal Fund Management, LLC / ABBV

Royal Fund Management, LLC’s Abbvie Inc Position

Does Royal Fund Management, LLC own Abbvie Inc (ABBV)? Yes — 47.2K shares worth $10M (+0.98% of its 13F portfolio) as of Q1 2026, up from 44.1K shares the prior filed quarter.

Position Value
$10M
Q1 2026
Shares
47.2K
% of Portfolio
+0.98%
Quarters Held
25
currently held

Position History ABBV

Reported value by quarter
Q1 ’20: $8MQ1 ’20Q2 ’20: $4MQ3 ’20: $4MQ4 ’20: $4MQ1 ’21: $4MQ1 ’21Q2 ’21: $4MQ3 ’21: $4MQ4 ’21: $5MQ1 ’22: $6MQ1 ’22Q2 ’22: $6MQ3 ’22: $5MQ4 ’22: $7MQ1 ’23: $7MQ1 ’23Q2 ’23: $7MQ3 ’23: $7MQ4 ’23: $7MQ1 ’24: $9MQ1 ’24Q2 ’24: $8MQ3 ’24: $10MQ4 ’24: $8MQ1 ’25: $9MQ1 ’25Q2 ’25: $9MQ3 ’25: $8MQ4 ’25: $10MQ1 ’26: $10MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202647.2K$10M+0.98%
Q4 202544.1K$10M+0.92%
Q3 202534.1K$8M+0.94%
Q2 202546.2K$9M+0.85%
Q1 202543.0K$9M+1.01%
Q4 202444.5K$8M+0.75%
Q3 202449.0K$10M+0.58%
Q2 202446.7K$8M+0.65%
Q1 202447.3K$9M+0.85%
Q4 202347.9K$7M+0.82%
Q3 202348.1K$7M+0.97%
Q2 202349.4K$7M+0.83%
Q1 202345.4K$7M+1.04%
Q4 202242.5K$7M+1.09%
Q3 202239.1K$5M+0.95%
Q2 202241.2K$6M+1.05%
Q1 202239.3K$6M+0.92%
Q4 202140.3K$5M+0.78%
Q3 202139.8K$4M+0.63%
Q2 202139.1K$4M+0.73%
Q1 202139.9K$4M+0.79%
Q4 202038.3K$4M+0.87%
Q3 202040.7K$4M+0.91%
Q2 202045.2K$4M+1.56%
Q1 202093.7K$8M+2.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Royal Fund Management, LLC’s full portfolio or all institutional holders of ABBV.